(Reuters) -Consumer healthcare firm Haleon on Thursday forecast high single-digit growth for its 2024 organic operating profit, after it posted a 4% rise in half-year pre-tax earnings amid strong demand for its oral care products and vitamins.
Haleon, the maker of popular household products such as Sensodyne toothpaste, Panadol painkillers and Eno antacids, in May estimated its annual organic operating profit growth to be higher than its revenue forecast of between 4% and 6%.
Analysts, on average, expect full-year profit growth of 7.8%, according to a company-compiled poll.
The company said its adjusted pre-tax profit for the six-month period ended June 30 was 1.13 billion pounds, almost in line with market view of 1.14 billion pounds.
(Reporting by Aby Jose Koilparambil in Bengaluru; Editing by Sherry Jacob-Phillips)
